Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Helius Medical Technologies ( (HSDT) ) has provided an update.
On November 3, 2025, Solana Company, previously known as Helius Medical Technologies, shared a corporate presentation and a press release on their website. These documents, which are part of a Current Report, include forward-looking statements and are intended for informational purposes only, highlighting potential risks and uncertainties associated with the company’s future operations and financial projections.
The most recent analyst rating on (HSDT) stock is a Sell with a $6.50 price target. To see the full list of analyst forecasts on Helius Medical Technologies stock, see the HSDT Stock Forecast page.
Spark’s Take on HSDT Stock
According to Spark, TipRanks’ AI Analyst, HSDT is a Underperform.
Helius Medical Technologies is currently facing significant financial and operational challenges, with declining revenue and profitability. The technical analysis indicates a bearish trend, and the valuation metrics are unfavorable due to negative earnings. These factors collectively result in a low overall stock score.
To see Spark’s full report on HSDT stock, click here.
More about Helius Medical Technologies
Average Trading Volume: 935,996
Technical Sentiment Signal: Strong Sell
Current Market Cap: $239.4M
Learn more about HSDT stock on TipRanks’ Stock Analysis page.